B56.0

Clinical Causes: Transmission through the bite of infected tsetse flies (Glossina species). The parasite infects both humans and animals, maintaining the cycle of transmission. Living in areas endemic to tsetse flies increases risk, especially in rural regions with dense vegetation. Limited awareness or access to healthcare can delay diagnosis and treatment, allowing the disease to progress. Infections generally occur in tropical and subtropical climates, particularly during certain seasons when fly populations are high.

Key Symptoms: Early-stage symptoms include fever, headaches, joint pains, and fatigue. Swollen lymph nodes, especially at the back of the neck, known as Winterbottom’s sign. Skin rashes and itching may also be present. As the disease advances, neurological symptoms develop, such as confusion, sleep disturbances, and behavioral changes. In late stages, individuals may experience tremors, poor coordination, and paralysis. Untreated cases can result in coma and death due to neurological failure.

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Microscopic examination of blood, lymph node aspirates, or cerebrospinal fluid can reveal the parasitic trypomastigotes. Serological tests may support diagnosis, especially in endemic areas. Imaging studies are not typically used for detection but may assist in assessing neurological damage if present.

Treatment Protocols: Treatment depends on the disease stage. Early-stage gambiense trypanosomiasis is usually treated with specific antiparasitic medications like pentamidine, which target the parasite in the bloodstream. For late-stage or neurological involvement, drugs such as eflornithine or nifurtimox are employed to cross the blood-brain barrier and eliminate parasites in the central nervous system. Supportive care and management of symptoms are also essential aspects of treatment. Complete adherence to therapy is vital to prevent relapse and complications.